Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Oeffl, N; Schober, L; Faudon, P; Schweintzger, S; Manninger, M; Köstenberger, M; Sallmon, H; Scherr, D; Kurath-Koller, S.
Antiarrhythmic Drug Dosing in Children-Review of the Literature.
Children (Basel). 2023; 10(5): Doi: 10.3390/children10050847 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Führende Autor*innen der Med Uni Graz
Kurath-Koller Stefan
Öffl Nathalie Maria
Co-Autor*innen der Med Uni Graz
Faudon Patrick
Koestenberger Martin
Manninger-Wünscher Martin
Sallmon Hannes
Scherr Daniel
Schober Lukas
Schweintzger Sabrina
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Antiarrhythmic drugs represent a mainstay of pediatric arrhythmia treatment. However, official guidelines and consensus documents on this topic remain scarce. There are rather uniform recommendations for some medications (including adenosine, amiodarone, and esmolol), while there are only very broad dosage recommendations for others (such as sotalol or digoxin). To prevent potential uncertainties and even mistakes with regard to dosing, we summarized the published dosage recommendations for antiarrhythmic drugs in children. Because of the wide variations in availability, regulatory approval, and experience, we encourage centers to develop their own specific protocols for pediatric antiarrhythmic drug therapy.

Find related publications in this database (Keywords)
children
antiarrhythmic drugs
arrhythmia
electrophysiology
drug dosing
© Med Uni Graz • Impressum